GOLGA8N

Across TCGA pan-cancer cohorts, GOLGA8N RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated GOLGA8N data layer compared with 2 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher GOLGA8N RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated GOLGA8N expression acts as an unfavorable survival marker, although some lineages such as HNSC and MESO show a favorable association.

HNSC, KIRC, and LGG are the cancer types where GOLGA8N RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.764	0.632	.001	86	view →
KIRC	DFS	Quartile	All	0.441	0.734	<.001	45	view →
LGG	DFS	Median	All	0.659	0.809	<.001	42	view →
MESO	DFS	Tertile	II,III,IV	0.478	0.280	.013	39	view →
UVM	DFS	Median	III,IV	0.208	0.740	.006	31	view →
PAAD	DFS	Quartile	All	0.580	0.352	.002	26	view →
LIHC	DFS	Quartile	III,IV	0.523	0.147	.002	23	view →
KIRP	DFS	Median	All	1.000	0.785	.001	20	view →
READ	DFS	Tertile	IV	0.256	0.699	.003	20	view →
UCS	DFS	Quartile	II,III,IV	0.565	0.196	<.001	18	view →
LUAD	OS	Tertile	All	0.871	0.765	.010	17	view →
BLCA	DFS	Quartile	IV	0.221	0.530	.028	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

GOLGA8N–HNSC (DFS)

Open the HNSC breakdown →